Literature DB >> 19602774

High-normal blood pressure and the risk of cardiovascular disease.

Yoshihiro Kokubo1, Kei Kamide.   

Abstract

The guidelines of the Joint National Committee 7 from the USA on hypertension have unified the normal and high-normal blood pressure categories into a single entity termed ;prehypertension'. In contrast, The European Guidelines for the management of hypertension in 2007 considered ;prehypertensive' to be divided into normal and high-normal blood pressure. These patients with high-normal blood pressure or prehypertension might progress to hypertension over time. Previous studies have shown that high-normal blood pressure is a risk factor for cardiovascular disease (CVD) in Western countries and Japan. The combination of high-normal blood pressure and other cardiovascular risk factors increases the risks of CVD. Recently, metabolic syndrome has also been shown to be a risk factor for CVD. In Japan, the association between metabolic syndrome and CVD was also found to be significant. The risks for CVD incidence were similar among participants who had the same number of components, regardless of the presence of abdominal obesity. In the Japanese guidelines for the management of hypertension published in 2009, patients are considered to be in a high-risk group if they have diabetes, chronic kidney disease, 3 or more risk factors, target organ damage or CVD, even if they have only high-normal blood pressure, and appropriate antihypertensive therapy should be initiated.

Entities:  

Mesh:

Year:  2009        PMID: 19602774     DOI: 10.1253/circj.cj-09-0336

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  12 in total

1.  Principal component 1 score calculated from metabolic syndrome diagnostic parameters is a possible marker for the development of metabolic syndrome in middle-aged Japanese men without treatment for metabolic diseases.

Authors:  Kazuki Mochizuki; Rie Miyauchi; Yasumi Misaki; Yoko Ichikawa; Toshinao Goda
Journal:  Eur J Nutr       Date:  2011-12-09       Impact factor: 5.614

2.  Self-reported faster eating is positively associated with accumulation of visceral fat in middle-aged apparently healthy Japanese men.

Authors:  Kazuki Mochizuki; Masami Yamada; Rie Miyauchi; Yasumi Misaki; Nobuhiko Kasezawa; Kazushige Tohyama; Toshinao Goda
Journal:  Eur J Nutr       Date:  2013-11-21       Impact factor: 5.614

Review 3.  RhoA/Rho-kinase and vascular diseases: what is the link?

Authors:  Kenia Pedrosa Nunes; Christine S Rigsby; R Clinton Webb
Journal:  Cell Mol Life Sci       Date:  2010-07-29       Impact factor: 9.261

4.  The state of U.S. living kidney donors.

Authors:  Connie L Davis; Mathew Cooper
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-15       Impact factor: 8.237

5.  Developing and validating a new precise risk-prediction model for new-onset hypertension: The Jichi Genki hypertension prediction model (JG model).

Authors:  Hiroshi Kanegae; Takamitsu Oikawa; Kenji Suzuki; Yukie Okawara; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-31       Impact factor: 3.738

6.  Which blood pressure measurement, systolic or diastolic, better predicts future hypertension in normotensive young adults?

Authors:  Hiroshi Kanegae; Takamitsu Oikawa; Yukie Okawara; Satoshi Hoshide; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-04-26       Impact factor: 3.738

7.  Antihypertensive medication versus health promotion for improving metabolic syndrome in preventing cardiovascular events: a success rate-oriented simulation study.

Authors:  Yoichi Ohno; Satomi Shibazaki; Ryuichiro Araki; Takashi Miyazaki; Mayuko Hanyu; Makiko Satoh; Tsuneo Takenaka; Hirokazu Okada; Hiromichi Suzuki
Journal:  BMC Med Inform Decis Mak       Date:  2011-02-13       Impact factor: 2.796

8.  Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment?

Authors:  Yoshihiro Kokubo
Journal:  EPMA J       Date:  2011-04-02       Impact factor: 6.543

9.  Initial antihypertensive prescription and switching: a 5 year cohort study from 250,851 patients.

Authors:  Martin C S Wong; Wilson W S Tam; Clement S K Cheung; Ellen L H Tong; Antonio C H Sek; George John; N T Cheung; Bryan P Y Yan; C M Yu; Stephen Leeder; Sian Griffiths
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

10.  Increased clearance of reactive aldehydes and damaged proteins in hypertension-induced compensated cardiac hypertrophy: impact of exercise training.

Authors:  Juliane Cruz Campos; Tiago Fernandes; Luiz Roberto Grassmann Bechara; Nathalie Alves da Paixão; Patricia Chakur Brum; Edilamar Menezes de Oliveira; Julio Cesar Batista Ferreira
Journal:  Oxid Med Cell Longev       Date:  2015-04-14       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.